Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
Article in Frontiers in Oncology (March 2023)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
Article in Journal of Neuro-Oncology (February 2023)
Circulating Tumor DNA in Lymphoma
Book chapter (January 2023)